Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report: June 11, 2008
(Date of earliest event reported)
OCULUS INNOVATIVE SCIENCES, INC.
(Exact name of registrant as specified in its charter)
         
Delaware   001-33216   68-0423298
         
(State or Other Jurisdiction
of Incorporation)
  (Commission File Number)   (I.R.S. Employer
Identification Number)
     
1129 N. McDowell Blvd.    
Petaluma, California   94954
     
(Address of principal executive offices)   (Zip Code)
(707) 782-0792
(Registrant’s telephone number,
including area code)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


TABLE OF CONTENTS

Item 2.02 Results of Operations and Financial Condition
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
SIGNATURE
EXHIBIT INDEX
EXHIBIT 99.1


Table of Contents

Item 2.02 Results of Operations and Financial Condition.
On June 11, 2008, Oculus Innovative Sciences, Inc. issued a press release announcing financial results for its fiscal year ended March 31, 2008. The full text of the press release is furnished as Exhibit 99.1.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
(d) Exhibits
             
 
    99.1     Press release issued by Oculus Innovative Sciences, Inc. dated June 11, 2008.

 


Table of Contents

SIGNATURE
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     Dated: June 11, 2008
         
  OCULUS INNOVATIVE SCIENCES, INC.
 
 
  By:   /s/ Robert Miller    
    Robert Miller   
     
  Chief Financial Officer  
  (title)  
     

 


Table of Contents

         
EXHIBIT INDEX
     
Exhibit No.   Description
 
99.1
  Press release issued by Oculus Innovative Sciences, Inc. dated June 11, 2008